Use of early postoperative intraperitoneal 5-fluorouracil with index cytoreduction improves survival with secondary cytoreductive surgery.

Published in: Journal of surgical oncology (2023)

Use of EPIC 5-FU at a complete index CRS was a prognostic variable that improved survival in patients requiring SCRS. Further investigations into the benefits of antiadhesion treatments with CRS and HIPEC are warranted.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
minimally invasive
chronic kidney disease
peritoneal dialysis
coronary artery bypass
atrial fibrillation
patient reported